News
Key reasons to buy the Global Dodecanedioic Acid Market report: ...
Enhanced procedures included standard cystoscopy + blue light cystoscopy, mapping bladder biopsies, retrograde pyelograms, upper tract cytology, and prostatic urethral biopsies. Importantly, these ...
Treatment with a custom-made vaccine combination was found to be safe and feasible for patients with bladder cancer, ...
It can also show any blockages in the tubes that move urine between your kidneys and bladder, known as the ureters. Cystoscopy is a test to look at the inside of your bladder and check for signs of ...
Join leading experts to discuss how we are ushering in a new era in bladder cancer care on May 28 virtually. Register now.
UroGen Pharma ( NASDAQ: URGN) announced on Wednesday that the U.S. FDA has scheduled an Oncologic Drugs Advisory Committee ...
considering that 80% of those with NMIBC “see their disease return” and nearly half may require bladder-removal surgery, principal trial investigator Maria De Santis, M.D., highlighted in AZ's ...
1d
Clinical Trials Arena on MSNAstraZeneca’s Imfinzi combo shows DFS improvement in bladder cancer trialThe trial was conducted across over 120 centres in 12 nations, including Canada, and regions across Asia and Europe.
Bladder cancer is a cancer that forms in tissues of the bladder. Most bladder cancers are transitional cell carcinomas (cancer that begins in cells that normally make up the inner lining of the ...
The subtypes investigated in bladder cancer were CK19, CK20 and CK7 IHC/RT-PCR CK20: 56–46% [98,99]; CK7: 100% [99]; CK1: 93.1% [101] Association of CK19 with UPII detected pN0 patients with ...
The HUGO robotic-assisted surgery system showed a high surgical success rate and favorable rates of grade 3 complications.
Advanced transitional-cell carcinoma of the bladder is the most common cancer of the urinary tract, with a high mortality rate. Cisplatin-based chemotherapy has demonstrated prolonged survival of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results